Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay
Open Access
- 6 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (10) , 676
Abstract
Background: Alpha-internexin (AINX) is a type IV intermediate filament alongside the neurofilament triplet proteins and periferin. Despite its homologies, the key difference is that AINX is central nervous system-specific. The purpose of this study was to develop an immunoassay for cerebrospinal fluid (CSF) AINX, quantify it in patients with neurodegenerative diseases, and compare its diagnostic performance with neurofilament light (NfL). Methods: Monoclonal antibodies were generated and characterized by immunoprecipitation followed by mass spectrometry and ELISA, for specificity to the target analyte and cross-reactivity. Single molecule array (Simoa) technology was the selected platform for assay development. The assay was validated according to pre-established parameters and AINX performance as a biomarker was tested in two independent cohorts (Gothenburg and University College London). Results: Two highly specific antibodies were generated (B15 and Ina1) and used to develop a robust assay in all analytical validation parameters tested. The quantitative range of the assay was 0.137–140 pg/mL. In the Gothenburg cohort, AINX and NfL showed similar diagnostic performance, but the correlation between biomarkers was diagnosis dependent. In the University College London cohort, AINX and NfL showed similar trends across the different neurodegenerative diseases, with strong correlation between markers. Conclusions: We developed a highly sensitive and specific immunoassay for AINX in CSF. AINX showed similar diagnostic performance and high correlation with CSF NfL. Further research should focus on describing its role in specific disorders, as well as evaluate its potential as a blood-based biomarker.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (860197)
- Vetenskapsrådet (#2023-00356, #2022-01018, #2019-02397, #2017-00915, #2022-00732)
- University of Gothenburg
This publication has 38 references indexed in Scilit:
- α-Internexin Is Present in the Pathological Inclusions of Neuronal Intermediate Filament Inclusion DiseaseThe American Journal of Pathology, 2004
- ?-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseasesActa Neuropathologica, 2004
- Neurofilament light protein and glial fibrillary acidic protein as biological markers in MSNeurology, 2003
- No requirement of α-internexin for nervous system development and for radial growth of axonsMolecular Brain Research, 1999
- Distribution of neuronal intermediate filament proteins in the developing mouse olfactory systemJournal of Neuroscience Research, 1998
- Roles of head and tail domains in α-internexin’s self-assembly and coassembly with the neurofilament triplet proteinsJournal of Cell Science, 1998
- Expression of the gene for the neuronal intermediate filament protein α‐internexin coincides with the onset of neuronal differentiation in the developing rat nervous systemJournal of Comparative Neurology, 1994
- Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brainJournal of Neuroscience, 1990
- Characterization of a novel 66 kd subunit of mammalian neurofilamentsNeuron, 1989
- alpha-Internexin, a 66-kD intermediate filament-binding protein from mammalian central nervous tissues.Journal of Cell Biology, 1985